RHYTHM PHARMACEUTICALS, INC.

Profile

Company Names

RHYTHM PHARMACEUTICALS, INC.

Addresses

855 BOYLSTON STREET, 11TH FLOOR, BOSTON, MA 02116

200 CLARENDON STREET, 54TH FLOOR, BOSTON, MA 02116

Phone Numbers

617 428 6390

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$40,500,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2012-05-25 
$22,500,000.00 
$42,500,000.00 
$20,000,000.00 
Equity 
1
2010-03-09 
$18,000,000.00 
$40,000,000.00 
$22,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTIAN 
 
DE LA TOUR 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  RHYTHM HOLDING COMPANY, LLC
TODD 
 
FOLEY 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  ZALICUS INC.   |  CELLADON CORP   |  SELEXYS PHARMACEUTICALS CORP   |  PROTEON THERAPEUTICS INC   |  ICONIC THERAPEUTICS INC   |  VALERITAS INC   |  TETHEREX PHARMACEUTICALS CORP   |  CLINICAL INK, INC.   |  SEMMA THERAPEUTICS, INC.   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  MOAT BIOTECHNOLOGY CORP   |  CROSSBOW THERAPEUTICS, INC.   |  FIREFLY BIO, INC.   |  AKTIS ONCOLOGY, INC.
KEITH 
 
GOTTESDIENER 
EXECUTIVE OFFICER, DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  RHYTHM HOLDING COMPANY, LLC   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  CARDURION PHARMACEUTICALS, INC.
BART 
 
HENDERSON 
EXECUTIVE OFFICER, DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  RHYTHM HOLDING COMPANY, LLC   |  RHYTHM METABOLIC, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  TORQUE THERAPEUTICS, INC.
VAUGHAN 
 
KAILIAN 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.
EDWARD 
 
MATHERS 
DIRECTOR
RA PHARMACEUTICALS, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  SATORI PHARMACEUTICALS INC   |  MIRNA THERAPEUTICS, INC.   |  RHYTHM HOLDING COMPANY, LLC   |  LUMENA PHARMACEUTICALS, INC.   |  LUMOS PHARMA, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  LIQUIDIA TECHNOLOGIES INC   |  INOZYME PHARMA, INC.   |  SYNLOGIC, INC.   |  AFFINIA THERAPEUTICS INC.   |  CODE BIOTHERAPEUTICS, INC.   |  TREVI THERAPEUTICS, INC.   |  SORRISO PHARMACEUTICALS, INC.   |  MBX BIOSCIENCES, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  BRENIG THERAPEUTICS, INC.   |  SENTI BIOSCIENCES, INC.   |  SENTI BIOSCIENCES HOLDINGS, INC.   |  SENTI HOLDINGS, INC.   |  SENTI BIOSCIENCES, INC.
STEVEN 
 
ST. PETER 
DIRECTOR
PHARMATHENE, INC   |  XANODYNE PHARMACEUTICALS INC   |  MPM BIOVENTURES V, L.P.   |  RHYTHM PHARMACEUTICALS, INC.   |  ARATANA THERAPEUTICS, INC.   |  PROTEON THERAPEUTICS INC
LOU 
 
TARTAGLIA 
DIRECTOR
RHYTHM PHARMACEUTICALS, INC.   |  ZAFGEN, INC.   |  RHYTHM HOLDING COMPANY, LLC   |  CROSSLINK THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-12-04
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-25 
2012-06-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-25 
2010-08-30
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-09 
2010-03-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-03-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#